Plain-English translation of NCT05538338 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing platelet rich plasma (PRP)—a concentrated preparation made from your own blood—to see if it can help thicken the uterine lining in people who have struggled with thin endometrium during fertility treatment. Some patients will receive the treatment infusion, while others will receive a placebo (salt water). All participants will then proceed with a frozen embryo transfer as planned.
A thin uterine lining is a common reason why embryo transfers fail, and current treatments don't always work. Researchers hope this medication, made from a patient's own blood components, may help the lining grow thicker and give embryos a better chance of implanting successfully.
You likely qualify if…
You likely don't qualify if…
You will receive a single infusion of either the treatment or placebo directly into your uterus, performed at the fertility clinic. After the infusion, you will proceed with your frozen embryo transfer as normally scheduled. The study is designed to be double-blind, meaning neither you nor your doctor will know which treatment you received until the study is complete, ensuring unbiased results.
AI-generated summary from trial data · Aug 22, 2026 · Not medical advice
United States